Clinical Trials Directory

Trials / Terminated

TerminatedNCT00835874

Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.

Detailed description

Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supplementation in most NICUs. Considering the proven immunomodulatory effect of maternal probiotics on breastfed infants of atopic mothers, we would like to explore the indirect effects of maternal probiotics on preterm infants

Conditions

Interventions

TypeNameDescription
DRUGProbioticsLactobacillus acidophilus, b.lactis capsule. Once daily.2X 10 by the power of 10 bacteria per dose.

Timeline

Start date
2007-06-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2009-02-04
Last updated
2012-08-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00835874. Inclusion in this directory is not an endorsement.